1 E UROpean network of transnational collaborative RTD projects in the field of NANOMEDicine

1

www.euronanomed.net

EUROpean network of transnational collaborative RTD projects

in the field of NANOMEDicine

www.euronanomed.net2

What are the societal needs? - the challenge for Europe

Improve public health and welfare– Ageing population– Efficiency of current medical

solutions– Emergence of new disease and old

diseases are back– Personalized medicine future

directions


The global challenge

• Therapeutic solutions for only 1/3 known diseases (WHO)

• Infections: HIV, TB, malaria, risk of pandemia

• Need to increase capability and innovation of medical industry– Rapid and accurate diagnosis for

early detection, even prevention– Novel, more efficient therapies with

less side effects


Nano from research to patient and industry

Nanomedicine: the application of nanotechnology to achieve breakthroughs in healthcare

Foto: kaibara87/www.flickr.com


Principle of theERA-net scheme

F

G

UK

ES

DE

CP

CP

CP

CP

CP

Without ERA-Net

Prog

FProg

GProg

UKProg

ESProg

DE

Common transnational dedicated CP

With ERA-Net

…

(CP: Call for projects)

€ : EC supports the coordination costs. Each national programme supports their national partners within the selected projects


Who we are

24 partners (agencies and ministries) from 18 countries/regions

Aligning parts of their national / regional funding programs according to the FP7 ERA-Net scheme

Started January 2009 for 3 years

EU funding for coordination (for coordination (FP7)

3 common joint calls for proposals 2009, 2010, 2011

EuroNanoMed achieves a critical mass of actors

Joint trans-national RTD projectsin nanomedicine


EuroNanoMed: an asset to bridge the gap

Develop innovative diagnostic and therapeutic solutions for the patient

Solving unmet medical needs

Enhancing the competitiveness of the European health industry

Maturation of the Nanomedicine field in Europe

Cross-border collaboration between the best researchers / teams in Nanomedicine, bringing together teams from

academic / public research

clinical / public health

industry

Aims of the Calls


Why now? What’s the urgency?

• Health industry: a key for future growth

• European countries invest substantially in nano industry and basic nano research

• Nano technologies: a promising field for innovation and patient application

Despite these efforts, Europe is lagging behind the US in an increasing competition :

Europe needs to act now!


Expected outcome

• To move innovation from knowledge to industrial technology and health care applications

• Opening the national programmes to support transnational RTD partnerships

Long term vision: formula for an European-

wide integrated programme with a coordinated funding


Contacts

• Coordinator and Executive Board ChairDr. Virginie Sivan Commissariat à l’Energie Atomique (CEA)[email protected] (+33) 1 69 08 87 99

• Network Steering Committee chair Dr. Olaf RotthausVDI Technologiezentrum GmbH (VDI)[email protected] (+49) 211 6214-233


Joint Transnational Calls for proposals : RESULTS

JTC-1: 2009

JTC-2: 2010


RESULTS JTC-1 and JTC-2

Submitted projects 24 33Partners 117 178

Country/region 19 19

Funded projects 8 8Partners 40 46

Country/region 14 10

Success rate 33% 24%

Total costs (M€) 16.9 15.9

Requested budget (M€) 9.4 9

JTC-1 2009 JTC-2 2010


Submitted projectsPartners distribution /country-region

JTC-1 JTC-2


JTC-1 2009

Submitted projects Category of partners

Consortium composition

Three categories

Two categories(required)

Translational collaboration

Three categories

Two categories(required)


48%52%


48%52%


Translational Collaboration

61%

39%

JTC-2 2010


Submitted projects Main scientific subfields

JTC-1 2009 JTC-2 2010


Funded projectsPartners /country-region

France 8

Spain 8

Germany 7

Sweden 4

Switzerland 3

The Netherlands 2

Denmark (NPC) 1

Island 1

Italy (NPC) 1

Veneto Region 1

Lithuania 1

Poland 1

Portugal 1

Basque Region 1

France 10

Germany 9

Sweden 6

Portugal 5

Switzerland 5

Spain 5

Romania 3

Poland 1

Turkey 1

Latvia 1

JTC-1 2009 JTC-2 2010

Total 40

Total 46


-gene therapy-Immunotherapy-photodynamic therapy-anti-cancer therapies-development of vaccines-regeneration of the nervous system and sensory organs.

-cancer-inflammatory diseases-bone regeneration-muscular dystrophy-immunology-vaccines

JTC-1 2009 JTC-2 2010

Funded projectsMain scientific subfields


EuroNanoMed: open Call

3rd Joint Transnational

Call for Proposals

14 Countries / Regions

Deadline: April 15th 2011


Participating Funding Organisations

Industry, Innovation, Trade and Tourism Department, Basque Government

The French National Research Agency (ANR)VDI Technologiezentrum GmbHThe Icelandic Centre for Research (RANNIS)The Chief Scientist Office, The Ministry of Health (CSO-MOH)The Latvian Academy of Sciences (LAS)Science Council of Lithuania (LSC)National Centre for Research and Development (NCBiR)Unitatea Executiva pentru Finantarea Invatamantului Superior,

a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)Instituto de Salud Carlos III (ISCIII)Swiss National Science Foundation (SNSF)The Scientific and Technological Research Council of Turkey

(TUBITAK)Project Unit research and innovation, Veneto RegionMinistry of the Walloon Region: Operational General

Directorate for Economy, Employment,and Research (DGOEER)

BASQUE REGION (SPAIN)

FRANCEGERMANYICELANDISRAELLATVIALITHUANIAPOLANDROMANIA

SPAINSWITZERLANDTURKEY

VENETO REGION (ITALY)WALLOON REGION (BELGIUM)


Topics / Funding

Diagnostics Targeted

drug delivery

Regenerative medicine

Topics

Indicative total funding 11 M €

Duration: Up to 3 years

Every project partner will receive the funding from his national agency

Funding


Eligibility criteria

Consortium composition3 – 7 partners per consortium

Partners from at least 3 different countries (with a majority of partners from funding member states/regions participating in the call)

Partners from at least two of the three categories academic / public research

clinical / public health

industry

Eligibility of partners also depends on national regulation in their country or region!

Read carefully the “Country specific information for applicants”

Contact your national agency (contact person)


Time lines

Call open since: January 14th 2011

Deadline for proposals: April 15th 2010, 17:00:00 (Brussels Time)

Funding Decision: October 2011

Start of Projects: January 2012


How to apply?

1. EuroNanoMed Website

www.euronanomed.net


How to apply?

2. Download Call Text , Guidelines for applicants and Country specific Information


How to apply?

3. Contact your national contact point (list in the Country-region specific information)

4. Download and fill in the Proposal Template


How to apply?

5. Online Submission using the EuroNanoMed Submission Tool

www.nanomedsubmission.net


How to apply?

Register by clicking on the link ”to register” on the homepage http://www.euronanomed.net/*; you will receive an email confirming your registration

Accede to the EuroNanoMed Electronic Submission System* (Use the username and password you chose for the registration) fill in all the details and upload your proposal document (pdf format only), which you have previously filled in on your computer (see The Proposal Template)*.

Submit your proposal : Click on “submit proposal” to confirm your submission; you will receive an email confirming its receipt.

Modify your data at any time until the submission deadline. It is strongly recommended to transfer the final version in proper time before this date


Expression of Interest Tool

Present your project ideas

Find partners

www.nanomedsubmission.net


For more information

Veneto Nanotech s.c.p.a.Via San Crispino, 10635129 Padova – Italy

: +39 049 7705520

e-mail: [email protected]

EuroNanoMed Call Office

National / Regional Contact Points

www.euronanomed.net

30

www.euronanomed.net

Together we are building Nanomedicine for the future!

Documents

1 E UROpean network of transnational collaborative RTD projects in the field of NANOMEDicine